Subchronic Exposure to Ellagic Acid Impairs Cytotoxic T-Cell Function and Suppresses Humoral Immunity in Mice
Public Domain
-
2003/10/01
Details
-
Personal Author:
-
Description:Ellagic acid (EA) is present in a variety of foods such as grapes, strawberries, raspberries, and nuts. It is a dietary plant phenol that has been shown to inhibit oxidative stress and chemical carcinogenesis. Although several studies have examined the protective mechanisms of dietary EA including the induction of detoxifying enzymes, regulation of cell cycle, chelation of nickel, and prevention of DNA methylation, none have addressed the role of EA in immunological surveillance. This study investigates the status of immune function in B6C3F1 mice exposed continuously to EA in drinking water at 0.5, 1.0, or 2.0 mg/kg/day for 28 days. Although this range of exposure is above the estimated human daily intake (is approximately equal to 940 µg/day for 70 kg person or 13.4 µg/kg/day), these levels would not be unreasonable if EA were used as a dietary supplement or as a chemotherapeutic agent. Previous reports have demonstrated the anticarcinogenic effects of EA at levels 10- to 250-fold greater than those applied in this study. Immunological parameters assessed included natural killer (NK) cell activity, cytotoxic T lymphocyte (CTL) activity, IgM antibody plaque forming cell (PFC) response, thymus, spleen, kidney, and liver mass, and total cellularity for the thymus and spleen. Subchronic exposure to EA for 28 days in drinking water caused significant suppression of specific IgM antibody responses in the 2.0 mg/kg EA treatment group and suppressed cytotoxic T-cell function in the 0.5 and 1.0 mg/kg EA treatment groups. All other immunological parameters were within normal ranges. Kidney and liver mass were not altered after treatment with EA. The results from this study indicate that EA suppressed both IgM antibody responses and CTLs. These observations suggest important implications on human health should EA be prescribed as a chemotherapeutic agent or a preventative dietary supplement for cancer. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0892-3973
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:409-422
-
Volume:25
-
Issue:3
-
NIOSHTIC Number:nn:20024030
-
Citation:Immunopharmacol Immunotoxicol 2003 Oct; 25(3):409-422
-
Contact Point Address:National Institute of Occupational Safety and Health, Agriculture and Immunotoxicology Group, MS-L1119, 1095 Willowdale Road, Morgantown, WV 26505-2888, USA
-
Email:dkeil@cdc.gov
-
Federal Fiscal Year:2004
-
Peer Reviewed:True
-
Source Full Name:Immunopharmacology and Immunotoxicology
-
Collection(s):
-
Main Document Checksum:urn:sha-512:2b08df7ecd11cf9c94a52dee565860375d547e0ea4de003bf50883ab9ecf2da300090692d057a8b8fbee9585578fa2f9100817180f31e0adc060c83c00e42d60
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like